Keynote Presentations include:
Dr. Patricia Conrod, Ph.D, Clinician psychologist, Professor at the Université of Montréal, Department of Psychiatry. The personality-targeted approach to treating substance use problems was first developed and tested by Dr. Patricia Conrod at McGill University in Montreal, Canada (1995-2000). For more info on Dr. Conrod's work click here.
Dr. Anna Ratzliff is a national expert on collaborative care and specifically on training teams to implement and deliver mental health treatment in primary care settings. Her passion for translating complex research ideas into practical real-world applications began when she received her MD and PhD in Anatomy and Neurobiology as part of the Medical Scientist Training Program at the University of California at Irvine. She currently is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington where she has developed expertise in suicide prevention training, mental health workforce development, adult learning best practices, and mentorship. Dr. Ratzliff is the Director of the AIMS Center (Advancing Integrated Mental Health Solutions), is the Director of the UW Integrated Care Training Program for residents and fellows, and leads a national collaborative care training program for the American Psychiatric Association’s Transforming Clinical Practices Initiative grant. For more information on collaborative care please visit the AIMS Center website and the UW Integrated Care Training Program website.
Dr. Evan Wood, MD, PhD, ABIM, FASAM, FRCPC, ABAM Diplomat, is the Director of the British Columbia Centre on Substance Use based at St. Paul’s Hospital in Vancouver. He is also a professor of medicine at the University of British Columbia, where he helps lead the university’s efforts in the area of addiction prevention and treatment through a Tier 1 Canada Research Chair. Dr. Wood is a general internal medicine specialist and diplomate of the American Board of Addiction Medicine who has been responsible for the creation of a number of addiction clinical and clinical training programs. His research is funded by the U.S. National Institute on Drug Abuse and CIHR through the Canadian Research Initiative on Substance Misuse.